1. Home
  2. WAVE vs SCYX Comparison

WAVE vs SCYX Comparison

Compare WAVE & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eco Wave Power Global AB (publ)

WAVE

Eco Wave Power Global AB (publ)

HOLD

Current Price

$5.82

Market Cap

47.5M

Sector

Utilities

ML Signal

HOLD

Logo SCYNEXIS Inc.

SCYX

SCYNEXIS Inc.

HOLD

Current Price

$5.05

Market Cap

44.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WAVE
SCYX
Founded
2011
1999
Country
Israel
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.5M
44.4M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
WAVE
SCYX
Price
$5.82
$5.05
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$14.75
★ $36.33
AVG Volume (30 Days)
19.1K
★ 259.2K
Earning Date
11-16-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 61.36
EPS
★ N/A
N/A
Revenue
N/A
★ $257,000.00
Revenue This Year
$360.53
N/A
Revenue Next Year
$42.86
$906.41
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.52
$0.57
52 Week High
$10.87
$6.09

Technical Indicators

Market Signals
Indicator
WAVE
SCYX
Relative Strength Index (RSI) 43.70 54.63
Support Level $5.49 $4.65
Resistance Level $6.55 $5.44
Average True Range (ATR) 0.46 0.43
MACD 0.04 0.07
Stochastic Oscillator 24.43 68.31

Price Performance

Historical Comparison
WAVE
SCYX

About WAVE Eco Wave Power Global AB (publ)

Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient wave energy conversion, or WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographically, it has a presence in Israel, the USA, and Mexico.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: